Jinhai Medical Technology (HKG:2225) received the results of the inquiry of the Securities and Futures Commission into the company's shareholding on
The results showed that 27 shareholders held 41.26% of the issued shares of the company and Chen Guobao, the company's chairman, held 48.94% of issued shares as of Nov. 20.
The shareholdings mentioned above make up 90.20% of the issued shares of the company leaving only 9.80% for other shareholders, a Monday Hong Kong bourse filing said.
SFC further mentioned that the company's shares' closing price rose by 77.65% to HK$9.06 on Nov. 20 from HK$5.10 on Sept. 13. The shares closed at HK$8.50 on Friday, representing an increase of 66.67% from HK$5.10 on Sept. 13.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.